---
authors:
- Carek, Stephen
- Yurgil, Jacqueline
- Mounsey, Anne
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36689977/
file_path: 2023/01/sglt-2-inhibitors-for-cardiovascular-outcomes-in-heart-failu.md
issue: '1'
keywords:
- Heart Failure
- Humans
- Heart
- Sodium-Glucose Transporter 2 Inhibitors
- Stroke Volume
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Sodium-Glucose Transporter 2 Inhibitors
- Stroke Volume
- Heart Failure
- Heart
original_format: PubMed
pages: 81-82
patient_population: Adults
peer_reviewed: true
pmid: '36689977'
processed_date: '2025-07-30'
publication_date: '2023-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved
  Ejection Fraction.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36689977'
  title: SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved
    Ejection Fraction.
  authors:
  - last_name: Carek
    fore_name: Stephen
    initials: S
    affiliation: University of South Carolina School of Medicine Greenville, Greenville,
      South Carolina.
  - last_name: Yurgil
    fore_name: Jacqueline
    initials: J
    affiliation: University of South Carolina School of Medicine Greenville, Greenville,
      South Carolina.
  - last_name: Mounsey
    fore_name: Anne
    initials: A
    affiliation: University of South Carolina School of Medicine Greenville, Greenville,
      South Carolina.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '1'
  publication_info:
    year: '2023'
    month: '01'
    full_date: '2023-01-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Sodium-Glucose Transporter 2 Inhibitors
    major_topic: true
  - descriptor: Stroke Volume
    major_topic: false
  - descriptor: Heart Failure
    major_topic: true
  - descriptor: Heart
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36689977'
  title: SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved
    Ejection Fraction.
  authors:
  - name: Carek S
    authtype: Author
    clusterid: ''
  - name: Yurgil J
    authtype: Author
    clusterid: ''
  - name: Mounsey A
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Jan
- pmid: '33792199'
  title: Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with
    heart failure with reduced or preserved ejection fraction?
  authors:
  - name: Singh AK
    authtype: Author
    clusterid: ''
  - name: Singh R
    authtype: Author
    clusterid: ''
  - name: Misra A
    authtype: Author
    clusterid: ''
  source: J Diabetes
  pubdate: 2021 Jul
- pmid: '35653033'
  title: 'SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned
    Recently?'
  authors:
  - name: Al Rifai M
    authtype: Author
    clusterid: ''
  - name: Newby LK
    authtype: Author
    clusterid: ''
  - name: Nair AP
    authtype: Author
    clusterid: ''
  - name: Misra A
    authtype: Author
    clusterid: ''
  - name: Rogers JG
    authtype: Author
    clusterid: ''
  - name: Fedson S
    authtype: Author
    clusterid: ''
  - name: Virani SS
    authtype: Author
    clusterid: ''
  source: Curr Atheroscler Rep
  pubdate: 2022 Aug
- pmid: '34881413'
  title: 'Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for
    Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.'
  authors:
  - name: Rao S
    authtype: Author
    clusterid: ''
  source: Adv Ther
  pubdate: 2022 Feb
- pmid: '34941199'
  title: 'Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved
    ejection fraction: A protocol for meta-analysis.'
  authors:
  - name: Fukuta H
    authtype: Author
    clusterid: ''
  - name: Hagiwara H
    authtype: Author
    clusterid: ''
  - name: Kamiya T
    authtype: Author
    clusterid: ''
  source: Medicine (Baltimore)
  pubdate: 2021 Dec 23
---

# SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction.

**Authors:** Carek, Stephen, Yurgil, Jacqueline, Mounsey, Anne

**Published in:** American family physician | Vol. 107, No. 1 | 2023-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36689977/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Heart Failure, Heart

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36689977/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
